DRTSW
Alpha Tau Medical Ltd. Warrant
$0.245+0.000 (0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.000
High
$0.000
Low
$0.000
Volume
0.00M
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
- Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, showing >90% disease control rate, impressive overall
View more
GlobeNewswire
Alpha Tau to Participate in May Investor Conferences
JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.